Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Fernandez

Showing results (201-210 of 235) with videos related to

Pageof 24
Sort By:
The Journal of Pathology|October 27, 2025
Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencingGeorgios Nteliopoulos, Evie Wren, Amelia Rushton, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Vaccines|January 21, 2023
Level of Knowledge Regarding Mpox among Peruvian Physicians during the 2022 Outbreak: A Cross-Sectional StudyJose A Gonzales-Zamora, David R Soriano-Moreno, Anderson N Soriano-Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer PatientsJavier Pascual, Miguel Gil-Gil, Paula Proszek, et al.
Genome Biology|June 24, 2016
Erratum to: Single cell analysis of CD4+ T cell differentiation reveals three major cell states and progressive acceleration of proliferationValentina Proserpio, Andrea Piccolo, Liora Haim-Vilmovsky, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Cell Chemical Biology|March 10, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.
ACS Omega|June 18, 2020
Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and PossibilitiesJyoti Ahlawat, Gileydis Guillama Barroso, Shima Masoudi Asil, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2018
IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage <i>Plasmodium</i> InfectionKylie R James, Megan S F Soon, Ismail Sebina, et al.
Pageof 24

Showing results (201-210 of 235) with videos related to

Sort By:
Pageof 24
The Journal of Pathology|October 27, 2025
Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencingGeorgios Nteliopoulos, Evie Wren, Amelia Rushton, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Vaccines|January 21, 2023
Level of Knowledge Regarding Mpox among Peruvian Physicians during the 2022 Outbreak: A Cross-Sectional StudyJose A Gonzales-Zamora, David R Soriano-Moreno, Anderson N Soriano-Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer PatientsJavier Pascual, Miguel Gil-Gil, Paula Proszek, et al.
Genome Biology|June 24, 2016
Erratum to: Single cell analysis of CD4+ T cell differentiation reveals three major cell states and progressive acceleration of proliferationValentina Proserpio, Andrea Piccolo, Liora Haim-Vilmovsky, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Cell Chemical Biology|March 10, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.
ACS Omega|June 18, 2020
Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and PossibilitiesJyoti Ahlawat, Gileydis Guillama Barroso, Shima Masoudi Asil, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2018
IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage <i>Plasmodium</i> InfectionKylie R James, Megan S F Soon, Ismail Sebina, et al.
Pageof 24